Effects of intravenous low-dose recombinant human atrial natriuretic peptide on renal function in the perioperative management for gastrointestinal perforation or ileus: A retrospective single-center study

Journal of Critical Care

Volumn 28, Issue 2, 2013, Pages 133-140

  Maruta, Toyoaki ^a,b   Otao, Go ^c   Miyazato, Takeshi ^a   Maruta, Nozomi ^a   Yamauchi, Koichiro ^c   Yano, Takao ^c   Kawano, Taro ^c   Tsuneyoshi, Isao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Nobeoka Prefectural Hospital   (Japan)

Author keywords

Acute renal injury; Human atrial natriuretic peptide; Perioperative management; Serum creatinine

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTRODUODENOSTOMY; HUMAN; ILEOTOMY; ILEUS; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; MORTALITY; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; COMORBIDITY; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; ILEUS; INTESTINAL PERFORATION; KIDNEY FUNCTION TESTS; MALE; PERIOPERATIVE CARE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 84875399500     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.07.020     Document Type: Article

References (30)

1. Brochard L., Abroug F., Brenner M., et al. ATS/ERS/ESICM/SCCM/SRLF Ad Hoc Committee on Acute Renal Failure. An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 2010, 181:1128-1155.
2. Uchino S., Kellum J.A., Bellomo R., et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
3. Martin R.K. Acute kidney injury: advances in definition, pathophysiology, and diagnosis. AACN Adv Crit Care 2010, 21:350-356.
4. Prowle J.R., Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2010, 16:332-336.
5. Rimmelé T., Kellum J.A. Oliguria and fluid overload. Contrib Nephrol 2010, 164:39-45.
6. Mehta R.L., Pascual M.T., Soroko S., et al. PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002, 288:2547-2553.
7. Bellomo R., Chapman M., Finfer S., et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143.
8. Karvellas C.J., Farhat M.R., Sajjad I., et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011, 15(1):R72. Epub 2011 Feb 25.
9. Chujo K., Ueno M., Asaga T., et al. Atrial natriuretic peptide enhances recovery from ischemia/reperfusion-induced renal injury in rats. J Biosci Bioeng 2010, 109:526-530.
10. Mitaka C., Hirata Y., Habuka K., et al. Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs. Crit Care Med 2003, 31:2205-2210.
11. Conger J.D., Falk S.A., Hammond W.S. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 1991, 40:21-28.
12. Pollock D.M., Opgenorth T.J. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure. J Pharmacol Exp Ther 1990, 255:1166-1169.
13. Rahman S.N., Kim G.E., Mathew A.S., et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994, 45:1731-1738.
14. Allgren R.L., Marbury T.C., Rahman S.N., et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997, 336:828-834.
15. Lewis J., Salem M.M., Chertow G.M., et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000, 36:767-774.
16. Nigwekar S.U., Navaneethan S.D., Parikh C.R., et al. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009, 4:261-272.
17. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
18. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
19. White L.E., Chaudhary R., Moore L.J., et al. Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res 2011, 167:306-315.
20. Zarjou A., Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011, 22:999-1006.
21. Mohmand H., Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 2011, 22:615-621.
22. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med 1998, 339:321-328.
23. Marin-Grez M., Fleming J.T., Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986, 324:473-476.
24. Oda J., Kasai K., Noborio M., et al. Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock. J Trauma 2009, 66:1281-1285.
25. Morikawa S., Sone T., Tsuboi H., et al. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 2009, 53:1040-1046.
26. Swärd K., Valsson F., Odencrants P., et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004, 32:1310-1315.
27. Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol 2010, 56:262-270.
28. Mitaka C., Kudo T., Haraguchi G., et al. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care 2011, 15:R258.
29. Sezai A., Hata M., Niino T., et al. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol 2011, 58:897-903.
30. Yoshitake I., Sezai A., Hata M., et al. Low-dose atrial natriuretic peptide for chronic kidney disease in coronary surgery. Ann Thorac Cardiovasc Surg 2011, 17:363-368.